Regulation of plasminogen activation on cell surfaces and fibrin

ISTH Academy, Tetsumei Urano, 227417

Thromboembolic risk after lumbar spine surgery: a cohort study on 325 000 French patients

ISTH Academy, Joel Coste, 227418

In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents

ISTH Academy, Friedrich Scheiflinger, 227419

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

ISTH Academy, Kimberly Legault, 227420

Clinical and economic impact of compression in the acute phase of deep vein thrombosis

ISTH Academy, Elham E. Amin, 227423

Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism

ISTH Academy, John-Bjarne Hansen, 227424

Hemorrhagic disorders of fibrinolysis: a clinical review

ISTH Academy, Joline L Saes, 227425

Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability

ISTH Academy, Sylvie Bouvier, 227426

The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban

ISTH Academy, Cristina Duboscq, 227427

The perils of inhibiting deficient factors

ISTH Academy, Zara Sayar, 227428

Stay Coagulated and Join the ISTH Today

ISTH Academy, Session Speakers, 227429

Molecular actions of heparin and their implications in preventing pre‐eclampsia

ISTH Academy, John C. Kingdom, 227430

TC21/RRas2 regulates glycoprotein VI–FcRγ‐mediated platelet activation and thrombus stability

ISTH Academy, Lawrence Goldfinger, 227431

Summertime

ISTH Academy, Session Speakers, 227432

Dual endothelin‐1 receptor antagonism attenuates platelet‐mediated derangements of blood coagulation in Eisenmenger syndrome

ISTH Academy, Fionnuala Ni Ainle, 227433

Move along, nothing to see here: Btk inhibitors stop platelets sticking to plaques

ISTH Academy, Alexander Paul Bye, 227434

Management of postpartum hemorrhage: how to improve maternal outcomes?

ISTH Academy, Johanna van der Bom, 227435

Pleiotropic effects of the hemostatic system

ISTH Academy, Henri Spronk, 227436

Issue Information

ISTH Academy, Session Speakers, 227438

Reduction in physical function in women after venous thromboembolism

ISTH Academy, Kaitlin A Hagan, 227439

An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study

ISTH Academy, Imre Bodó, 227440

Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity

ISTH Academy, John Morser, 227441

What the neighbors say

ISTH Academy, Session Speakers, 227442

Immune Thrombocytopenia: Pathophysiology and Treatment: Future Directions

ISTH Academy, Philip Choi, 223617

The Measurement of Mean Platelet Volume in the Differential Diagnosis of ITP: Case Report and State of the Art (Case Based Presentation)

ISTH Academy, Patrizia Noris, 223616

Low Dose DOACs for the Secondary Prevention of VTE (Case Based Presentation)

ISTH Academy, Jeffrey I. Weitz, 223621

Abnormal Bleeding in Mild/Moderate ITP: Case Report and the Role of Platelet Dysfunction (Case Based Presentation)

ISTH Academy, Andrew Frelinger, 223615

DOACs for the Treatment of VTE in Unusual Site VTE (Case Based Presentation)

ISTH Academy, Walter Ageno, 223620

Immune Platelet Disorders (Case Based Presentation)

ISTH Academy, Donald Arnold, 223614

DOACs for the Treatment of Cancer Associated Thrombosis (Case Based Presentation)

ISTH Academy, Marc Carrier, 223619

The Role of Platelets in Vascular Integrity and in the Prevention of Bleeding

ISTH Academy, Michael Berndt, 223613

Unmet Clinical Needs in the Management of Venous Thromboembolism

ISTH Academy, Sabine Eichinger, 223618

Sepsis Reconsidered

ISTH Academy, Clifford S. Deutschman, 223608

Targeting the Contact System for Treatment of Thrombo-Inflammatory Diseases

ISTH Academy, Thomas Renné, 223612

DIC in Sepsis and Obstetrics

ISTH Academy, Beverly Hunt, 223607

Medical Device Thrombosis- Causes and Prevention (Case Based Presentation)

ISTH Academy, Jeffrey I. Weitz, 223611

Sepsis: A Critical Care Physician Perspective

ISTH Academy, Jerry J. Zimmerman, 223606

Hereditary Angioedema - Examining a Complex Etiology (Case Based Presentation)

ISTH Academy, Marcel Levi, 223610

A Hemostasis Perspective on How to Mitigate Sepsis Mortality

ISTH Academy, Toshiaki Iba, 223605

Sepsis a Disorder of Coagulation or Platelets?

ISTH Academy, Dermot Cox, 223604

Resurrection of the Contact System - What We Now Know and What Remains to Be Determined

ISTH Academy, Coen Maas, 223609

Expert Commentary

ISTH Academy, Peter Lenting, 223706

Expert Commentary

ISTH Academy, Steven Pipe, 223707

Closing

ISTH Academy, Guy Young, 223708

Recommendations of the International Council for Standardization in Hematology (ICSH) for Laboratory Measurement of Direct Oral Anticoagulants (DOAC)

ISTH Academy, Robert Gosselin, 223727

The DaXa Inhibition Test: A Concept for a Universal and Easily Available aXa Test That Measures the Direct Inhibitory Effect of All Anti-Xa Drugs

ISTH Academy, Joost van Pelt, 223728

Reversal and Biological Strategies in French GIHP-NACO Registry: Need for Guidance

ISTH Academy, Pierre Albaladejo, 223729

Novel Approaches for Immune Tolerance Induction

ISTH Academy, David Lillicrap, 223698

Extended Half-Life Products and ITI

ISTH Academy, Manuel Carcao, 223699

Prophylaxis with ITI

ISTH Academy, Carmen Escuriola-Ettingshausen, 223700

Debate: ITI in the Era of Emicizumab - Yes

ISTH Academy, Ri Liesner, 223701

Debate: ITI in the Era of Emicizumab - No

ISTH Academy, Beatrice Nolan, 223702

Welcome and Introduction

ISTH Academy, Mark Crowther, 223723

DOACs Measurements and Clinical Events: Recent Evidences from the Literature and the Presentation of the MAS - Measure and See" Study"

ISTH Academy, Sophie Testa, 223724

Calibration of SSC/ISTH Plasma Standard Lot #5

ISTH Academy, Craig Thelwell, 223691

Calibration of WHO International Standard for Factor V

ISTH Academy, Anthony Hubbard, 223692

Hemophilia Carriers Nomenclature

ISTH Academy, Robert F. Sidonio Jr., 223693

Gene Therapy Clinical Trials

ISTH Academy, Alok Srivastava, 223694

EHC Partners Programme

ISTH Academy, Brian O'Mahony, 223695

Plasminogen Deficiency

ISTH Academy, Charles Nakar, 223696

Diagnosing Rare Platelet Disorders

ISTH Academy, Diane Nugent, 223697

Impact of DOACs on LAC Testing: The Australian Perspective

ISTH Academy, Jennifer Curnow, 223714

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOAC on Several Tests for Thrombophilia Screening

ISTH Academy, Francois Mullier, 223715

Unusual Site Thrombosis Treated with DOACs

ISTH Academy, Nicoletta Riva, 223717

CVT Registry

ISTH Academy, Francesco Dentali, 223718

START Events registry

ISTH Academy, Sophie Testa, 223719

ORTHO-START registry

ISTH Academy, Elvira Grandone, 223720

DOAC Testing in Ontario: Results from IQMH

ISTH Academy, Karen Moffat, 223721

Venous Stent Registry

ISTH Academy, Sam Schulman, 223722

Introduction to SSC Sessions

ISTH Academy, Guy Young, 223684

Top Abstract Presentation: Enhanced FIX Collagen IV Binding Shows Improved Hemostatic Effects in a Hemophilia B Mouse Model

ISTH Academy, Davide Matino, 223685

Treatment of Breakthrough Bleeds

ISTH Academy, Peter Collins, 223686

Laboratory Issues

ISTH Academy, Stefan Tiefenbacher, 223688

Surveillance and Monitoring for Adverse Events

ISTH Academy, Flora Peyvandi, 223689

Institute for Clinical and Economic Review of Emicizumab

ISTH Academy, David Rind, 223690

Welcome and Introduction

ISTH Academy, Mark Crowther, 223709

Top Abstract Presentation: Outcomes in Non-Valvular Atrial Fibrillation Patients with Good and Poor INR Control After Switching to Direct Oral Anticoagulants

ISTH Academy, Scott Kaatz, 223710

Is Laboratory Monitoring of DOAC Required in Patients with APS- Insight from the Canadian RAPS Study

ISTH Academy, Kim Legault, 223713

Novel Approaches to Pharmacokinetics and Individualized Pharmacologic Dosing of Factor Products

ISTH Academy, Peter Collins, 223597

Why It Is Safe to Continue Antithrombotics for Some Procedures and Not Others?

ISTH Academy, Peter Verhamme, 223603

Using Electronic Data to Manage Hemophilia

ISTH Academy, Niamh O'Connell, 223596

Perioperative Prevention of Thromboembolism: An Asian Perspective

ISTH Academy, Heng Joo Ng, 223602

Hemophilia A With Inhibitors (Case Based Presentation)

ISTH Academy, Carmen Escuriola-Ettingshausen, 223595

Determinants of Bleeding in a Perioperative Setting (Case Based Presentation)

ISTH Academy, Charles Marc Samama, 223601

Hemophilia B (Case Based Presentation)

ISTH Academy, Johnny Mahlangu, 223594

Determinants of Acute Coronary Syndromes in a Perioperative Setting

ISTH Academy, Ursula Rauch-Kröhnert, 223600

Hemophilia A (Case Based Presentation)

ISTH Academy, Beatrice Nolan, 223593

The Role for Laboratory Testing Before Urgent Surgery (Case Based Presentation)

ISTH Academy, Adam Cuker, 223599

The History of Hemophilia Replacement Therapy: From Samuel Lane to Extended Half-Life Factor Replacement Therapy

ISTH Academy, Kathelijn Fischer, 223592

Perioperative Mechanisms of Thrombosis

ISTH Academy, John-Bjarne Hansen, 223598

Direct Oral Anticoagulant Use in Obese Patients: Preliminary Results of a Pilot Study

ISTH Academy, Laura Talamo, 213461

Change of Rivaroxaban Anticoagulant Effect during the 24 Hours

ISTH Academy, Olesia Matvienko, 213684

D-dimer Levels for Prediction of Symptomatic Central Venous Catheter-related Thrombosis in Breast Cancer Patients

ISTH Academy, Ilham Benzidia, 213756

Risk of Recurrent Venous Thromboembolism in Pregnancy and Postpartum Period: Results from the MEGA Follow-up Study

ISTH Academy, Luuk J.J. Scheres, 213787

Variable Response in Individuals to Rivaroxaban and Apixaban over Time

ISTH Academy, Suzanne zwaveling, 213879

Stability of Thrombin Generation and Thrombin Dynamics in Healthy Individuals over a One-year Period

ISTH Academy, Joke Konings, 213911

Knowledge Derived from a Hospitalar Thromboprophylaxis Program

ISTH Academy, maria chindamo, 213942

Clinical Characteristics and Outcome of Patients with Subsegmental Pulmonary Embolism

ISTH Academy, Farès Moustafa, 213970

The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism

ISTH Academy, Éva Katona, 214021

Anticoagulation Monitoring of Pediatric Patients on Life Support Sytems Using a Microfluidic Device that Mimics Complex Vascular Architecture

ISTH Academy, David Luna, 214045